Monday, June 15, 9:00 – 10:30 am
Auditorium Lulli

Chairs: Markus Moehler (Germany) – Christelle De la Fouchardiere (France) – Manfred Lutz (Germany) 

1. Early-onset gastroesophageal cancer – a distinct entity? – Irit Ben-Aharon (Israel)
2. Pro: First choice Chemo (instead of CROSS) in adenocarcinoma of esophagus. – Eduardo Terán (Spain)
3. Contra: First choice CROSS (instead Chemo) in adenocarcinoma of esophagus. – Mike Gibson (USA)
4. Recurrences after neoadj therapy: local endoscopic resections or irradiation? – Manfred Lutz (Germany)
5. Management of Metastatic Disease. – Aziz Zaanan (France)
6. De-escalation strategies in oesogastric adenocarcinomas: is the time right? – Christelle De la Fouchardiere (France)
7. MSI: how do we treat, w+w or operate? – Thierry André (France)
8. ASCO 2026: New important SOC-changing phase III trials? – Lucjan Wyrwicz (Poland)
9. Multidisciplinary Tumor Board-Harmonizing other Local and Systemic Control in Gastric or Gastroesophageal Cancer. – Hanoch Kashtan (Israel)
10. Sport program and Resilience: what helps in perioperative setting? – Katja Petrowski (Germany)

Session Format:
Presentations: Eleven topics will be addressed with prepared presentations.
Each speaker will be given 8 minutes to discuss the assigned topic.